We are live on ! Find out more
AIP

ARS Investment Partners Portfolio holdings

AUM $2.29B
1-Year Est. Return 113.95%
This Fund
S&P 500
This Quarter Est. Return
+8.47%
1 Year Est. Return
+113.95%
3 Year Est. Return
+260.1%
5 Year Est. Return
+332.48%
10 Year Est. Return
+1,634.5%
AUM
$776M
AUM Growth
+$52.3M
Cap. Flow
-$2.62M
Cap. Flow %
-0.34%
Top 10 Hldgs %
32.35%
Holding
160
New
11
Increased
54
Reduced
57
Closed
8

Top Buys

Rank Stock Value
1
C icon
Citigroup
C
+$5.5M
2
CELG
Celgene Corp
CELG
+$5.34M
3
CY
Cypress Semiconductor
CY
+$5.06M
4
BIIB icon
Biogen
BIIB
+$4.64M
5
AMGN icon
Amgen
AMGN
+$3.22M

Top Sells

Rank Stock Value
1
MDT icon
Medtronic
MDT
+$8.32M
2
SWKS icon
Skyworks Solutions
SWKS
+$5.72M
3
LOW icon
Lowe's Companies
LOW
+$4.64M
4
IBM icon
IBM
IBM
+$3.45M
5
SPA
Sparton
SPA
+$2.42M

Sector Composition

Rank Sector Weight
1 Technology 27.64%
2 Industrials 12.88%
3 Communication Services 11.38%
4 Healthcare 9.87%
5 Consumer Discretionary 6.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DBRG icon
151
DigitalBridge
DBRG
$2.92B
$179K 0.02%
3,572
CLF icon
152
Cleveland-Cliffs
CLF
$6.49B
$157K 0.02%
22,000
MARA icon
153
Marathon Digital Holdings
MARA
$3.83B
-7,038
Closed -$43K
MDT icon
154
Medtronic
MDT
$112B
-93,745
Closed -$8.32M
SWKS icon
155
Skyworks Solutions
SWKS
$9.21B
-59,580
Closed -$5.72M
TGNA
156
DELISTED
TEGNA Inc
TGNA
-35,000
Closed -$6K
XOP icon
157
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
$3.54B
-1,583
Closed -$202K
ZD icon
158
Ziff Davis
ZD
$2B
-8,188
Closed -$606K
SEV
159
DELISTED
Sevcon, Inc.
SEV
-64,550
Closed -$865K
RELY
160
DELISTED
Real Industry, Inc.
RELY
-129,619
Closed -$376K

Similar funds

ARS Investment Partners's Q3 2017 Portfolio in Review

As of Q3 2017, ARS Investment Partners held 160 positions worth $776M, up 7.2% from $724M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

ARS Investment Partners's Q3 2017 filing shows 11 new, 54 increased, 57 reduced and 8 closed positions. Its largest new stake was Biogen: 15,671 shares worth $4.91M. The largest sale was Medtronic, an estimated $8.32M.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 27% a quarter earlier, followed by Industrials and Communication Services.

  • ARS Investment Partners's largest Q3 2017 buy was Biogen: 15,671 shares worth $4.91M.
  • ARS Investment Partners added most to Citigroup in Q3 2017, an estimated $5.5M increase.
  • ARS Investment Partners's biggest Q3 2017 reduction was Lowe's Companies, cutting an estimated $4.64M.
  • ARS Investment Partners fully exited Medtronic in Q3 2017, selling an estimated $8.32M.
  • ARS Investment Partners's ten largest holdings make up 32% of its $776M portfolio in Q3 2017.
  • ARS Investment Partners opened 11 new positions and closed 8 in Q3 2017.
  • ARS Investment Partners's portfolio value rose 7.2% quarter-over-quarter to $776M.

Based on ARS Investment Partners's 13F filing for Q3 2017, filed 14 Nov 2017.